Initial clinical impact of drug eluting stents on coronary artery bypass graft surgery

Interactive Cardiovascular and Thoracic Surgery

Volumn 6, Issue 5, 2007, Pages 632-635

  Kanemitsu, Shinji ^a   Tanaka, Keizo ^a   Tanaka, Jin ^a   Suzuki, Hitoshi ^a   Kinoshita, Toshihiko ^a  

^a ANJO KOSEI HOSPITAL   (Japan)

Author keywords

Angioplasty; Coronary artery bypass; Drug eluting stent; Off pump

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; HEART EJECTION FRACTION; HEART SURGERY; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; CORONARY ARTERY ATHEROSCLEROSIS; HOSPITALIZATION; INSTRUMENTATION; JAPAN; MIDDLE AGED; PATIENT REFERRAL; PATIENT SELECTION; PROSTHESIS; RADIOGRAPHY; RESTENOSIS; RETROSPECTIVE STUDY; STATISTICS; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

CARDIOVASCULAR AGENT; RAPAMYCIN;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PATIENT SELECTION; PROSTHESIS DESIGN; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 34848894809     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2007.159798     Document Type: Article

References (15)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R, RAVEL study group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE, SIRIUS Investigators. Sirolimus-eluting stents vs. standard stents in patients with stenosis in native coronary artery. N Engl J Med 2003;349:1315-1323.
3. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME, TAXU-SIV Investigators. One year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent the TAXUS IV trial. Circulation 2004;109:1942-1947.
4. Windecker S, Meier B. Intervention in coronary artery disease. Heart 2000;83:481-490.
5. Serruys PW, Unger F, van Hout BA, van den Brand MJ, van Herwerden LA, van Es GA, Bonnier JJ, Simon R, Cremer J, Colombo A, Santoli C, Vandormael M, Marshall PR, Madonna O, Firth BG, Breeman A, Morel MA, Hugenholtz PG. The ARTS study (Arterial Revascularization Therapies Study). Semin Interv Cardiol 1999;4:209-219.
6. van den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, Suryapranata H, Haalebos MM, Wijns W, Wellens F, Balcon R, Magee P, Ribeiro E, Buffolo E, Unger F, Serruys PW. The effect of completeness of revascularization on event free survival at one year in the ARTS trial. J Am Coll Cardiol 2002;39:559-564.
7. Drachman DE, Edelman ER, Seifert P, Groothuis AR, Bornstein DA, Kamath KR, Palasis M, Yang D, Nott SH, Rogers C. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth after six months. J Am Coll Cardiol 2000;36:2325-2332.
8. Williams DO, Holubkov R, Yeh W, Bourassa MG, Al-Bassam M, Block PC, Coady P, Cohen H, Cowley M, Dorros G, Faxon D, Holmes DR, Jacobs A, Kelsey SF, King SB 3rd, Myler R, Slater J, Stanek V, Vlachos HA, Detre KM. Percutaneous coronary interventions in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute registries. Circulation 2000;102:2945-2951.
9. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-1878.
10. Rensing BJ, Vos J, Smits PC, Foley DP, van den Brand MJ, van der Giessen WJ, de Feijter PJ, Serruys PW. Coronary restenosis elimination with a sirolimus eluting stent - first European human experience with 6-month angiographic and intravascular follow-up. Eur Heart J 2001 Nov;22:2125-2130.
11. Sousa JE, Costa MA, Abizaid AC, Rensing BJ, Abizaid AS, Tanajura LF, Kozuma K, Van Langenhove G, Sousa AG, Falotico R, Jaeger J, Popma JJ, Serruys PW. Sustained suppression on neointimal proliferation by sirolimus-eluting stents. One year angiographic and intravascular ultrasound follow-up. Circulation 2001;104:2007-2011.
12. Ben-Gal Y, Mohr R, Uretzky G, Medalion B, Hendler A, Hansson N, Herz I, Moshkovitz Y. Drug-eluting stents vs. arterial myocardial revascularization in patients with diabetes mellitus. Thorac Cardiovasc Surg 2006;132:861-866.
13. Liddicoat JR, De La Torre R, Ho KK, Nathan S, Levitsky S, Krempin J, Sellke F. Initial impact of drug-eluting stents on coronary artery bypass graft surgery. Ann Thorac Surg 2006;81:1239-1242.
14. Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, Kar S, Dohad S, Kass R, Eigler N, Trento A, Shah PK, Makkar RR. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2006;47:864-870.
15. Pinto Slottow TL, Waksman R. Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent thrombosis. Catheter Cardiovasc Interv 2007;69:1064-1074.